Position in PRGO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$303,502
-$5,036 QoQ
Shares Held
29,211
+1.7% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#160
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $16,343,377 across 32 Drug Manufacturers - Specialty & Generic names. PRGO ranks #22 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
40,027 | $2,097,414 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,432 | $1,859,560 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
10,634 | $1,792,254 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
134,034 | $1,340,340 | |
| 5 | LQDA |
Liquidia Corp
|
7,836 | $624,764 | |
| 6 | ZTS |
Zoetis Inc.
|
7,784 | $559,358 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,462 | $552,345 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
22,419 | $551,731 |
All Filings in PRGO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $303,502 | 29,211 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $308,538 | 28,728 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $454,000 | 32,615 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $364,916 | 16,386 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $427,012 | 15,981 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $472,642 | 16,856 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $453,884 | 17,654 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $520,586 | 19,847 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $523,563 | 20,388 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $763,933 | 23,732 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $688,137 | 21,384 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $679,129 | 21,256 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $662,092 | 19,502 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $742,867 | 20,710 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $531,633 | 15,595 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $523,952 | 14,693 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $651,391 | 16,056 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $669,642 | 17,425 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $624,811 | 16,062 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $764,900 | 16,161 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $569,365 | 12,418 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $456,582 | 11,282 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $546,880 | 12,229 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $557,163 | 12,136 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $753,606 | 13,635 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $587,275 | 12,212 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||